• Dermatology Times
Dermatology Times and Multimedia Medical, LLC
Dermatology Times and Multimedia Medical, LLC
Spotlight
American College of Mohs Surgery MeetingPerspectives on Advanced Basal Cell CarcinomaPrecision Medicine and BiologicsA Game Changer in Chronic inflammation ManagementPerspectives on Generalized Pustular PsoriasisSociety of Dermatology Nurse Practitioners
Topics
View MoreAcneAnti-AgingAtopic Dermatitis Hair & ScalpImpetigoNP and PAPsoriasis RosaceaSkin Cancer (Melanoma)Skin Cancer (Non-Melanoma)Vitiligo
News
Device Technology
Drug Watch
Legal
Lifestyle
NP and PA
Practice Management
Media
Around the Practice
Dermview
Dermview: Vitiligo
Editorial Board News
Expert Interviews
Inside the Clinic
Medical World News
Podcasts
Readout360
Viewpoints
Webinars
Conferences
Conference Coverage
Conference Listing
Publication
Dermatology Times
CME/CE
Resources
Image IQ
Interactive Tools
Job Board
Partnerships
Polls
Sponsored Content
Sponsored Resources
Editorial Board
Subscribe
eNewsletter
Print Subscription
  • Advertise
  • Contact Us
  • Job Board
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy Policy
  • About Us

© 2022 MJH Life Sciences and Dermatology Times and Multimedia Medical, LLC. All rights reserved.

Spotlight
  • American College of Mohs Surgery Meeting
  • Perspectives on Advanced Basal Cell Carcinoma
  • Precision Medicine and Biologics
  • A Game Changer in Chronic inflammation Management
  • Perspectives on Generalized Pustular Psoriasis
  • Society of Dermatology Nurse Practitioners
TopicsSee All >
  • Acne
  • Anti-Aging
  • Atopic Dermatitis
  • Hair & Scalp
  • Impetigo
  • NP and PA
  • Psoriasis
  • Rosacea
  • Skin Cancer (Melanoma)
  • Skin Cancer (Non-Melanoma)
  • Vitiligo
  • Advertise
  • Contact Us
  • Job Board
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy Policy
  • About Us
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ , Dermatology Times and Multimedia Medical, LLC. All rights reserved.

Understanding the Role of JAK Inhibitors

James Q. Del Rosso, DO, and Neal Bhatia, MD, discuss the role of topical and oral JAK inhibitors in inflammatory disease management.

EP. 1: JAK Inhibitors: An Overview

February 7th 2022

James Q. Del Rosso, DO, and Neal Bhatia, MD, provide an overview of JAK inhibitors for the treatment of atopic dermatitis.

EP. 2: Topical JAK Inhibitors for Atopic Dermatitis

February 14th 2022

A review of topical JAK inhibitor ruxolitinib.

EP. 3: Oral JAK Inhibitors for Atopic Dermatitis

February 21st 2022

Experts discuss newly approved oral JAK inhibitors for the treatment of atopic dermatitis.

EP. 4: JAK Inhibitors: Non-Responders and Safety Considerations

February 28th 2022

Drs James Q. Del Rosso and Neal Bhatia explain how to manage patients who fail therapy and provide safety considerations when treating those patients.